- £106.65m
- £172.78m
- £172.53m
Directorate change
Director/PDMR Shareholding
Brief: Foxtons Group Says All AGM Resolutions Passed Except 17 And 18
Brief: Foxtons Group Targets At Least £3 Million Annualised Savings Via Cost-Reduction Programme
Q1 2026 Trading Update
UK Stocks-Factors to watch on April 23
Media: Londons Foxtons cuts jobs, asks sales agents to move department- Bloomberg News
Director/PDMR Shareholding
Director/PDMR Shareholding
Notice of AGM and Annual Report and Accounts
Europe Research Roundup: Endesa ,Cosmo Pharmaceuticals, Oxford Biomedica
Holding(s) in Company
Director/PDMR Shareholding
Foxtons Group's 2025 revenue slightly beats view helped by acquisitions in commuter markets
Brief: Foxtons Group FY Pretax Profit GBP 16.9 Million
Full Year Results For Year Ended 31 December 2025
Holding(s) in Company
Board Change
Holding(s) in Company